The AIRLIFT™ procedure for sleep apnea has been developed by Siesta™ Medical, a privately held medical device company founded in 2009 to focus on a simple, effective and lasting treatment for obstructive sleep apnea (OSA). To perform the AIRLIFT procedure, Siesta Medical designed the Encore™ System and the Revolution™ Suture Passer, an integrated suite of instruments and implants designed to streamline hyoid and tongue suspension, enable efficient, simple implantation, decrease intraoperative time, and provide durable, positive outcomes.
OSA afflicts over 17 million people in the United States alone, with over one million new diagnoses made each year. OSA is associated with excessive daytime sleepiness, an increase in the incidence and risk of stroke, hypertension, heart disease, type II diabetes and heart failure.
The tongue base and/or hypopharynx is involved in an estimated 80% of OSA patients. While hyoid and tongue suspension have been promising approaches for treating these patients, existing instrument and implant options have proven to be difficult, painful, invasive and ineffective.
This has now changed. The AIRLIFT™ procedure, performed with the Encore™ System and the Revolution™ Suture Passer, addresses this unmet need with a simplified, effective and precisely-controlled approach to hyoid and tongue suspension.
President, Chief Executive Officer,
Mr. Martin has over 15 years of experience in medical device operations and development. Prior to Siesta, he served as CTO, VP of R&D and Operations for Paracor Medical. He also previously served as VP of Operations and Quality Assurance for Coalescent Surgical (acquired by Medtronic) and held operations management positions at W.L. Gore and Prograft Medical (acquired by W.L. Gore). Mr. Martin holds a BSME from Duke University and a MSMSE from Stanford University.
VP of Operations and Quality Assurance
Mr. Hinton has over 22 years of experience in Operations, Manufacturing and Quality roles, with more than 12 years in the Medical Device industry. Prior to joining Siesta Medical, he was Director of Manufacturing and Quality at Aptus Endosystems Inc., Senior Director of Operations at Paracor Medical Inc., and Director of Manufacturing Engineering at Coalescent Surgical, which was acquired by Medtronic. Prior to joining the Medical Device industry, Mr. Hinton spent 11 years in the hard disk drive industry where he held several Manufacturing and Product Engineering roles. Mr. Hinton holds a BSME from California Polytechnic State University, San Luis Obispo, CA.
Erik van der Burg
Chairman, Chief Technology Officer,
Mr. van der Burg has over 25 years of experience in medical device development and has over 75 issued patents in medical devices. Prior to his role with Siesta, he co-founded and served as CEO for Ross Creek Medical, which was acquired by Stryker. Prior to that, he co-founded and served as the CEO of Aspire Medical. Prior to his role with Aspire, he co-founded and served as VP of R&D at Appriva Medical (acquired by ev3). Mr. van der Burg holds a BSME from Cal Poly, SLO and a MSME from Santa Clara University.
VP of Regulatory Affairs & Clinical Research,
Mr. Kolber has over 20 years experience in medical device companies. Prior to Siesta Medical, Mr. Kolber was VP, Regulatory Affairs & Quality Assurance at Paracor Medical, Inc. Until recently, he served as Paracor’s GM. Mr. Kolber previously served as VP, Clinical Affairs, Regulatory Affairs & Quality Assurance at Appriva Medical (acquired by ev3). Prior to this, he was VP, Regulatory Affairs & Quality Assurance at Prograft Medical (acquired by W.L. Gore). He holds a B.S. in Zoology from San Diego State University, an MPH from UCLA and an MBA from Saint Mary’s College of Moraga.
Chief Financial Officer
Mr. Shukert is the consulting Chief Financial Officer for Siesta Medical. He has worked as a consulting CFO for development-phase biotechnology and medical device companies for more than 25 years. Mr. Shukert has helped raise and manage over $1.5 Billion to fund early-stage companies. His clients have included, Millennium Pharmaceuticals, CV Therapeutics, Prograft Medical, Spinal Kinetics, Millipede, Sutro Biopharma, Vaxcyte, Simplify Medical and PMV Pharma. Prior to his consulting work, Mr. Shukert was the Controller at Neurex Corporation. Prior to that, Mr. Shukert held successive financial management positions at Genentech and was a managing consultant at Andersen Consulting. Mr. Shukert earned an M.B.A. from the University of California-Berkeley and a B.S. in Civil Engineering from the University of Pennsylvania.
News & Events
PRESS RELEASES please click to read full press release
March 2, 2015
Siesta Medical Launches the Revolution™ Suture Passer
February 17, 2012
Siesta Medical Launches the Encore™ System
September 12, 2011
Siesta Medical Receives 510(k) Clearance for Encore™ System
U.S. Patent No. 8,460,322 B2
U.S. Patent No. 9,386,981 B2
U.S. Patent No. 9,463,014 B2
U.S. Patent No. 10,182,810 B2